Ani Pharmaceuticals reported $-3335000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aerie Pharmaceuticals AERI:US $ 51.74M 84.11M
Aurora Cannabis Inc ACB:CN C$ -97535000 46.99M
Canopy Growth Corp WEED:CN -111905000 100.94M
Depomed DEPO:US $ 5.93M 17.93M
Hikma Pharmaceutical HIK:LN 279M 1000K
Nektar Therapeutics NKTR:US $ -112910000 686K
Omeros OMER:US $ -35046000 65.69M
Sun Pharmaceuticals SUNP:IN 20.63B 1.13B
Teva Pharmaceutical TEVA:IT 971M 165M